Associate Consultant, Cardiology
National University Heart Centre, Singapore
Lead, CVD Prevention, Queenstown Health District (Singapore)
Clinical Lead, Cardiovascular Metabolic Translational Research Program, NUS
Dr Mayank Dalakoti completed his Bachelor’s in Medicine and Surgery (MBBS) from the National University of Singapore in 2013, Masters in Medicine (MMed) from the National University of Singapore and Membership of The Royal College of Physicians (MRCP), United Kingdom, in 2017. He completed his training in Internal Medicine at the National University Hospital in 2017, followed by Cardiology in 2022. He was awarded Valedictorian of the NUH Residency Program in 2022.
Dr Dalakoti’s focus and research within cardiology is in prevention and cardiometabolic medicine. Within NUHCS and the NUHS health district, he leads the population health approach to CVD prevention, working with primary care partners, public health specialists and regional health. This also involves work in digital healthcare to assist with cardiovascular disease risk stratification and interventions.
His research is in the identification of predictive biomarkers of early clinical cardiometabolic disease, with the aim of early therapeutic interventions, as well as health services research focusing on the implementation of novel digital-enabled population-level health interventions at scale. He is co-PI of the Platform for Interdisciplinary Cardiovascular-Metabolic Collaboration in NUHS (PICMAN) and Project RESET with Professor Roger Foo.